US FDA Commissioner Califf Takes On Misinformation, Starting With ‘Rumor Control’
Executive Summary
Agency leader expects to spend about a year developing a strategy to combat misinformation. On 5 August, the agency unveiled what appears to be an early component of the initiative – a web page titled Rumor Control, with facts about the safety and components of COVID-19 vaccines.
You may also be interested in...
Califf’s Top Priorities For New Year: Misinformation And Evidence Generation
FDA Commissioner is ‘pretty excited’ about obtaining high quality evidence in the postmarket space, noting agency's collaboration with NIH. He cites need to address the low cost of generic drugs as a factor in drug shortages.
Hard Truths About Mistruths: US FDA’s Califf Switching Gears On Misinformation Fight
Fighting misinformation likely will not be successful, the FDA commissioner concedes, but stakeholders should join the campaign to increase the dissemination of truthful information.
Hard Truths About Mistruths: US FDA’s Califf Switching Gears On Misinformation Fight
Fighting misinformation likely will not be successful, the FDA commissioner conceded, but stakeholders should join the campaign to increase the dissemination of truthful information.